• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The "7+3" regimen in acute myeloid leukemia.

作者信息

Rowe Jacob M

机构信息

Shaare Zedek Medical Center, Jerusalem, Israel.

出版信息

Haematologica. 2022 Jan 1;107(1):3. doi: 10.3324/haematol.2021.280161.

DOI:10.3324/haematol.2021.280161
PMID:34985228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8719100/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec99/8719100/3987932ea0b1/1073.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec99/8719100/3987932ea0b1/1073.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec99/8719100/3987932ea0b1/1073.fig1.jpg

相似文献

1
The "7+3" regimen in acute myeloid leukemia.急性髓系白血病的“7+3”方案
Haematologica. 2022 Jan 1;107(1):3. doi: 10.3324/haematol.2021.280161.
2
[FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2011 Jan;32(1):1-2.
3
Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.在异基因干细胞移植前，使用吉妥珠单抗奥唑米星和阿糖胞苷进行细胞减灭术治疗复发/难治性急性髓系白血病。
Leuk Lymphoma. 2012 Oct;53(10):2085-8. doi: 10.3109/10428194.2011.603450. Epub 2011 Sep 6.
4
Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia.关于氟达拉滨、阿糖胞苷、依托泊苷（FCE）治疗急性髓系白血病的事实。
Acta Haematol. 2014;131(4):200-1. doi: 10.1159/000355134. Epub 2013 Nov 27.
5
High dose cytarabine in acute myelogenous leukemia.
Bone Marrow Transplant. 1989 Jan;4 Suppl 1:38-42.
6
[Clinical outcome of CAG regimen in 26 children with aucte myeloid leukemia].[CAG方案治疗26例儿童急性髓系白血病的临床疗效]
Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):594-596. doi: 10.3760/cma.j.issn.0253-2727.2017.07.011.
7
Treatment of poor prognosis acute myeloid leukemia with aggressive and non-aggressive chemotherapy.采用积极和非积极化疗方案治疗预后不良的急性髓系白血病。
Chemioterapia. 1987 Jun;6(2 Suppl):723-4.
8
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?维奈托克联合去甲基化药物或小剂量阿糖胞苷治疗急性髓系白血病：闪光的都是金子吗？
Blood Cancer J. 2020 Jan 28;10(1):10. doi: 10.1038/s41408-020-0281-x.
9
[The clinical comparison of FLAG regimen versus IA regimen for newly diagnosed acute myeloid leukemia].[FLAG方案与IA方案治疗初诊急性髓系白血病的临床比较]
Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):141-3.
10
[Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations].
Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):653-5. doi: 10.3760/cma.j.issn.0253-2727.2014.07.019.

引用本文的文献

1
Advances in the Treatment of Acute Myeloid Leukemia: Implications for Low- and Middle-Income Countries.急性髓系白血病治疗进展：对低收入和中等收入国家的影响
Biomedicines. 2025 May 18;13(5):1221. doi: 10.3390/biomedicines13051221.
2
Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies.急性髓系白血病中的内质网应激：发病机制、预后意义及治疗策略
Int J Mol Sci. 2025 Mar 27;26(7):3092. doi: 10.3390/ijms26073092.
3
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.

本文引用的文献

1
Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968;32(4):507-523.埃里森·R·R、霍兰德·J·F、韦尔·M等。阿糖胞苷：治疗成人急性白血病的一种有效药物。《血液》。1968年；32(4):507 - 523。
Blood. 2016 Aug 18;128(7):883. doi: 10.1182/blood-2016-06-725101.
2
Management of adult acute myelogenous leukaemia.成人急性髓细胞白血病的管理
Br Med J. 1973 Jan 20;1(5846):131-7. doi: 10.1136/bmj.1.5846.131.
3
Acute promyelocytic leukemia: results of treatment by daunorubicin.
意大利FLT3突变急性髓系白血病患者队列研究（FLAM）的初始强化治疗分析：在现实环境中添加FLT3抑制剂至标准化疗的影响。
Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.
4
Acute Myelomonocytic Leukemia: A Rare Cause of Painless Jaundice.急性粒单核细胞白血病：无痛性黄疸的罕见病因
Cureus. 2025 Jan 10;17(1):e77223. doi: 10.7759/cureus.77223. eCollection 2025 Jan.
5
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives.单细胞RNA测序改善了急性髓系白血病治疗的新一代方法：挑战与展望。
Mol Med. 2025 Jan 30;31(1):33. doi: 10.1186/s10020-025-01085-w.
6
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes.FMNL1在髓系肿瘤中的新功能：从生物信息学到生物学及药理学领域的见解
Transl Cancer Res. 2024 Nov 30;13(11):6105-6116. doi: 10.21037/tcr-24-1091. Epub 2024 Nov 27.
7
Prognostic value of myeloid-derived suppressor-like cells in acute myeloid leukemia: insights from immunophenotyping and clinical correlations.髓系来源的抑制样细胞在急性髓系白血病中的预后价值：来自免疫表型分析和临床相关性的见解
Immunol Res. 2024 Dec 14;73(1):11. doi: 10.1007/s12026-024-09558-6.
8
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis.急性髓细胞白血病的化疗耐药性是由 A20 抑制自发坏死性凋亡介导的。
Nat Commun. 2024 Oct 24;15(1):9189. doi: 10.1038/s41467-024-53629-z.
9
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia.在既往未经治疗的成年急性髓系白血病患者中，使用低甲基化剂联合维奈克拉治疗的最佳反应结果。
Ann Hematol. 2025 Jan;104(1):307-315. doi: 10.1007/s00277-024-05976-6. Epub 2024 Sep 7.
10
Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case report.达雷妥尤单抗成功治疗难治性供者特异性人类白细胞抗原抗体诱导的原发性移植物功能衰竭：一例报告
EJHaem. 2024 Jun 19;5(4):863-866. doi: 10.1002/jha2.936. eCollection 2024 Aug.
Blood. 1973 Apr;41(4):489-96.